Danqing Xu

618 total citations
16 papers, 515 citations indexed

About

Danqing Xu is a scholar working on Molecular Biology, Organic Chemistry and Plant Science. According to data from OpenAlex, Danqing Xu has authored 16 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Plant Science. Recurrent topics in Danqing Xu's work include Natural Compound Pharmacology Studies (4 papers), Autophagy in Disease and Therapy (3 papers) and Plant-derived Lignans Synthesis and Bioactivity (3 papers). Danqing Xu is often cited by papers focused on Natural Compound Pharmacology Studies (4 papers), Autophagy in Disease and Therapy (3 papers) and Plant-derived Lignans Synthesis and Bioactivity (3 papers). Danqing Xu collaborates with scholars based in China, Switzerland and Hong Kong. Danqing Xu's co-authors include Hong‐Xi Xu, Naihan Xu, Yuanzhi Lao, Qiaojun He, Wei Xu, Zhenyan Liu, Gang Wan, Yaou Zhang, Xiaoyu Wang and Weidong Xie and has published in prestigious journals such as PLoS ONE, Free Radical Biology and Medicine and Molecules.

In The Last Decade

Danqing Xu

16 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danqing Xu China	13	305	174	104	73	69	16	515
Huey-Lan Huang Taiwan	14	349 1.1×	153 0.9×	76 0.7×	105 1.4×	31 0.4×	20	678
Yongqi Zhen China	15	400 1.3×	161 0.9×	41 0.4×	66 0.9×	107 1.6×	30	691
Meng-Wei Lin Taiwan	12	374 1.2×	123 0.7×	157 1.5×	103 1.4×	51 0.7×	12	650
Danhua Xiao United States	9	462 1.5×	49 0.3×	176 1.7×	70 1.0×	92 1.3×	9	806
Qin Deng China	8	226 0.7×	91 0.5×	26 0.3×	49 0.7×	31 0.4×	13	403
Ewa Totoń Poland	15	356 1.2×	97 0.6×	36 0.3×	31 0.4×	33 0.5×	38	558
Yadi Geng China	15	474 1.6×	90 0.5×	65 0.6×	62 0.8×	20 0.3×	20	718
Wen-Wen Huang Taiwan	16	469 1.5×	90 0.5×	92 0.9×	103 1.4×	66 1.0×	19	700
Noor Hasima Malaysia	8	283 0.9×	112 0.6×	22 0.2×	59 0.8×	37 0.5×	9	512
Sameer Ullah Khan India	11	270 0.9×	91 0.5×	36 0.3×	50 0.7×	33 0.5×	20	545

Countries citing papers authored by Danqing Xu

Since Specialization

Citations

This map shows the geographic impact of Danqing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danqing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danqing Xu more than expected).

Fields of papers citing papers by Danqing Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danqing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danqing Xu. The network helps show where Danqing Xu may publish in the future.

Co-authorship network of co-authors of Danqing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Danqing Xu. A scholar is included among the top collaborators of Danqing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danqing Xu. Danqing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Li, Han, Danqing Xu, Zhichao Xi, et al.. (2020). The Natural Compound Oblongifolin C Exhibits Anticancer Activity by Inhibiting HSPA8 and Cathepsin B In Vitro. Frontiers in Pharmacology. 11. 564833–564833. 6 indexed citations

Qiu, Yan, Danqing Xu, Yuanyuan Yang, et al.. (2018). Screening of FDA-approved drugs identifies sutent as a modulator of UCP1 expression in brown adipose tissue. EBioMedicine. 37. 344–355. 38 indexed citations

Xu, Hong‐Xi, et al.. (2017). Interactions between traditional chinese medicine and anticancer drugs in chemotherapy. World Journal of Traditional Chinese Medicine. 3(3). 38–38. 9 indexed citations

Zheng, Dan, Changwu Zheng, Yuanzhi Lao, et al.. (2017). Garciyunnanimines A–C, novel cytotoxic polycyclic polyprenylated acylphloroglucinol imines from Garcinia yunnanensis. Organic Chemistry Frontiers. 4(11). 2102–2108. 20 indexed citations

Xu, Danqing, Zhiheng Xu, Li Han, et al.. (2016). Identification of New ATG4B Inhibitors Based on a Novel High-Throughput Screening Platform. SLAS DISCOVERY. 22(4). 338–347. 27 indexed citations

Qiu, Zongxing, Bernd Kuhn, Johannes D. Aebi, et al.. (2016). Discovery of Fluoromethylketone-Based Peptidomimetics as Covalent ATG4B (Autophagin-1) Inhibitors. ACS Medicinal Chemistry Letters. 7(8). 802–806. 55 indexed citations

Zhang, Hong, Danqing Xu, Yuanzhi Lao, et al.. (2015). Xanthones from the Leaves of Garcinia cowa Induce Cell Cycle Arrest, Apoptosis, and Autophagy in Cancer Cells. Molecules. 20(6). 11387–11399. 35 indexed citations

Lao, Yuanzhi, Gang Wan, Zhenyan Liu, et al.. (2014). The natural compound oblongifolin C inhibits autophagic flux and enhances antitumor efficacy of nutrient deprivation. Autophagy. 10(5). 736–749. 119 indexed citations

Lin, Zhaohu, Chao Zhang, Meifang Zhang, et al.. (2014). Targeting Cadherin-17 Inactivates Ras/Raf/MEK/ERK Signaling and Inhibits Cell Proliferation in Gastric Cancer. PLoS ONE. 9(1). e85296–e85296. 36 indexed citations

10.

Xiao, Shiji, Xinxiang Lei, Bing Xia, et al.. (2014). Two novel polycyclic spiro lignans from Gymnotheca involucrata. Tetrahedron Letters. 55(43). 5949–5951. 16 indexed citations

11.

Xu, Danqing, Yuanzhi Lao, Naihan Xu, et al.. (2014). Identification and Characterization of Anticancer Compounds Targeting Apoptosis and Autophagy from Chinese Native Garcinia Species. Planta Medica. 81(1). 79–89. 33 indexed citations

12.

Zhang, Chao, Xihan Wu, Meifang Zhang, et al.. (2013). Small Molecule R1498 as a Well-Tolerated and Orally Active Kinase Inhibitor for Hepatocellular Carcinoma and Gastric Cancer Treatment via Targeting Angiogenesis and Mitosis Pathways. PLoS ONE. 8(6). e65264–e65264. 16 indexed citations

13.

Xu, Danqing, Ji Cao, Lin Li, et al.. (2010). 5k, a novel β-O-demethyl-epipodophyllotoxin analogue, inhibits the proliferation of cancer cells in vitro and in vivo via the induction of G2 arrest and apoptosis. Investigational New Drugs. 29(5). 786–799. 15 indexed citations

14.

Hu, Chunqi, Danqing Xu, Wenting Du, et al.. (2009). Novel 4β-anilino-podophyllotoxin derivatives: design synthesis and biological evaluation as potent DNA-topoisomerase II poisons and anti-MDR agents. Molecular BioSystems. 6(2). 410–420. 19 indexed citations

15.

Cao, Ji, Danqing Xu, Duoduo Wang, et al.. (2009). ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells. Free Radical Biology and Medicine. 47(5). 536–547. 65 indexed citations

16.

Xu, Danqing, Liang Fang, Qionghua Zhu, et al.. (2008). Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells.. PubMed. 63(7). 528–33. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact